Quality Systems – Page 258

E&L Failure after supplier change: sampling and mixing controls for QA review

E&L Failures Post-Supplier Change: Implementing Robust Sampling and Mixing Controls When a supplier is changed in pharmaceutical manufacturing, it can lead to significant risks, including extractables and leachables (E&L) failures.…

Assay Oos after supplier change: GMP documentation for FDA/EMA/MHRA review

Investigating Assay Out of Specification Following Supplier Change in GMP Environments In the complex landscape of pharmaceutical manufacturing, a change in supplier can introduce unexpected variability that may culminate in…

Microbial Limits Failure during method transfer: QMS trending and complaint handling expectations

Addressing Microbial Limits Failures During Method Transfer: A Comprehensive Investigation Guide Challenges in microbial limit testing are frequent topics of concern in pharmaceutical manufacturing, particularly during method transfer processes. When…

Texture Grittiness Complaint after supplier change: QMS trending and complaint handling expectations

Managing Texture Grittiness Complaints: A Comprehensive Guide for Pharmaceutical Investigations Pharmaceutical professionals are often confronted with complaints regarding product quality, particularly texture grittiness in dosage forms after a change in…

Hold Time Bioburden Rise after supplier change: investigation steps with CAPA evidence

Investigating Hold Time Bioburden Increase Following a Supplier Change: Effective Steps for CAPA In the fast-paced world of pharmaceutical manufacturing, changes in suppliers can lead to unforeseen challenges, including Quality…

Microbial Limits Failure in dental gel manufacturing: packaging compatibility and shelf-life justification

Investigating Microbial Limits Failure in Dental Gel Manufacturing: Insights on Packaging Compatibility and Shelf-Life Justification The pharmaceutical manufacturing industry faces numerous challenges, particularly when producing dental gels where microbial limits…

Flavor Instability after packaging change: manufacturing vs lab root cause assessment

Investigating Flavor Instability Post-Packaging Change in Pharmaceutical Manufacturing Flavor stability is crucial in pharmaceutical products, especially in dental dosage forms where taste plays a significant role in patient compliance. When…

Fill Weight Variability at accelerated stability: manufacturing vs lab root cause assessment

Assessing Root Causes of Fill Weight Variability in Accelerated Stability Studies In pharmaceutical manufacturing, maintaining consistent fill weights during production is critical, particularly when evaluating products under accelerated stability conditions.…

Ph Drift at accelerated stability: sanitation, water, and EM checks

Addressing pH Drift During Accelerated Stability Testing: Essential Investigative Steps pH drift observed during accelerated stability testing can pose significant challenges within pharmaceutical manufacturing, potentially impacting product quality and compliance.…

Tag: Quality Systems